An update on the management of refractory cutaneous lupus erythematosus

Management of cutaneous lupus erythematosus (CLE) involves a combination of preventive measures, topical and systemic drugs, fairly similar for the different subtypes. Although guidelines exist, to date, no specific drugs have been specifically licensed for CLE. Antimalarials remain the first-line s...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdelli, Alice, Corrà, Alberto, Mariotti, Elena Biancamaria, Aimo, Cristina, Ruffo di Calabria, Valentina, Volpi, Walter, Quintarelli, Lavinia, Caproni, Marzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537468/
https://www.ncbi.nlm.nih.gov/pubmed/36213629
http://dx.doi.org/10.3389/fmed.2022.941003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537468/
https://www.ncbi.nlm.nih.gov/pubmed/36213629
http://dx.doi.org/10.3389/fmed.2022.941003

Ejemplares similares